Richmond, VA, United States of America

Juan Wang

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Virginia Commonwealth University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan Wang. Retrieved from https://idiyas.com/inventor/juan-wang-12zhetps

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juan Wang - Innovator in Ophthalmological Treatments

Introduction

Juan Wang is a notable inventor based in Richmond, VA (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Juan Wang holds a patent for "Pilocarpine ionic liquids for treatment of glaucoma." This patent provides pilocarpine ionic liquid analogs that are useful in treating ophthalmological disorders such as glaucoma. His research focuses on improving the efficacy of treatments for patients suffering from this condition.

Career Highlights

Juan Wang is affiliated with Virginia Commonwealth University, where he conducts research and develops new therapeutic solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Juan collaborates with Hu Yang, a talented woman in the field, to further enhance their research efforts. Together, they aim to push the boundaries of what is possible in ophthalmological treatments.

Conclusion

Juan Wang's innovative contributions to the treatment of glaucoma exemplify the impact of dedicated research in the medical field. His work continues to inspire advancements in ophthalmology and improve the lives of patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…